S&P 500 analysts called Tesla’s stock break: what they say now

Analysts saw Tesla’s stock slump – almost to the dollar. And their calls now on the S&P 500 show what they think is coming.

X

Actions of Tesla (TSLA) fell more than 15% this year to 597.95 per share. That is almost certain for the 600 stock analysts who predicted that the electric carmaker’s shares would be worth it – in 12 months, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.

And if analysts call Tesla so well, what are they saying not only about Tesla’s future, but also about the other stocks in the S&P 500? It turns out that they still see big gains in some shares of the S&P 500 – but not at Tesla.

Analysts see many advantages of the S&P 500, but not with the Tesla

The S&P 500 has been skidding for a few weeks, especially in the technology sector. But analysts are still optimistic about most of the index’s stocks.

The S&P 500 fell 2.4% from the February 12 high. And the Technology Select Sector SPDR Fund (XLK) fell 7% in that period, the second worst performance of the 11 sectors of the S&P 500. The SPDR Fund for the Selected and Consumer Discretionary Sector (XLY) is the only sector that performs worse than The technology. And this is due to Tesla’s drop of more than 26% from February’s high.

But analysts still see opportunities. Analysts expect 297 S&P 500 shares to rise more than 5% in the next 12 months. And analysts are asking for gains of more than 30% on 13 shares of the S&P 500.

Tesla, however, is not one of them. So what’s the take on Tesla from here?

Analysts think the stock has less than 1% appreciation in 12 months, even after the fall. The Tesla’s 12-month price target is 600.14, not far from the 597.95 that closed on Friday.

To be sure, disagreement is rampant. Tesla’s most optimistic analyst has a 12-month target price of 1,200. But the most pessimistic think that the stock is only worth 135. Analysts, on average, classify Tesla’s shares as a hold. IBD Live viewers, however, learned to be cautious even earlier than analysts on January 8.

Investors may get some answers in April. Tesla is expected to earn 74 cents a share in the first quarter, an increase of more than 220% over the previous year.

Where analysts see the biggest advantages of the S&P 500

So if Tesla is not the S&P 500 that stock analysts are more optimistic about, what is it?

Analysts think information technology stocks Enphase Energy (ENPH) will be worth 227.13 a share in 12 months. If they are right, that would be an implicit positive side of 58%. The solar equipment company is called “outperform” by analysts. And shares have fallen 18% this year, to 143.55 per share.

Not all the positive side implied, however, is that the S&P 500’s shares have fallen so much this year. Analysts see promise in several stocks in the S&P 500 healthcare industry. Specifically, analysts think Centenary (CNC) will be 34% more in 12 months than it is now, to 81.38 per share. The company offers health services to people with insufficient insurance in the USA. The stock rose 0.8% this year to 60.53.

Therefore, analysts may not see much of an increase in Tesla’s shares now. But there are still many opportunities if you ask analysts.

S&P 500 stock analysts like it more now

Company	Symbol	Accumulated stock in the year% Ch.	Implicit Positive for the Analyst’s Target *	Closed Friday	Compound classification
Enphase Energy	(ENPH)	-18.2%	58.2%	143.55	Information Technology	81
Viatris	(VTRS)	-25.8%	41.2%	13.91	Health care	9
IPG Photonics	(IPGP)	-7.8%	37.9%	206.50	Information Technology	45
Regeneron Pharmaceuticals	(REGN)	-4.5%	37.7%	635.67	Health care	66
Equinix	(EQIX)	-14.5%	36.5%	833.08	Real estate	21
Synopsis	(SNPS)	-12.1%	35.1%	227.80	Information Technology	64
Amazon.com	(AMZN)	-7.9%	34.9%	3000.46	Discretionary Consumer	78
Centenary	(CNC)	0.8%	34.4%	60.52	Health care	54
Vertex Pharmaceuticals	(VRTX)	-10.3%	33.9%	211.98	Health care	57
Tesla **	(TSLA)	-15.3%	0.4%	597.95	Discretionary Consumer	38